The Global Biotech & Pharma Patent (China) Summit 2026 will bring together leading pharmaceutical companies, biotech firms, research institutions, law firms, intellectual property agencies, and industry experts from around the world. Centered on the core theme of "Focus on APAC Global Vision,Guided by Insight, Innovation Without Borders," and the summit will delve into patent strategies for cutting-edge technologies, global patent deployment and management, cross-border licensing and collaboration, as well as the latest trends in policies and ethics.We are in an era of global health revolution driven by biotechnological innovation. From gene editing to AI-driven drug discovery, disruptive technologies are redefining pharmaceutical R&D. In this process, intellectual property—particularly patents—serves not only as a legal shield but also as a core strategic asset determining the value of technology transfer and global collaboration.China has emerged as an indispensable presence in this landscape. With substantial R&D investment and a maturing ecosystem, it has transitioned from a "fast follower" to a "parallel leader," contributing original achievements across multiple fields while deepening global collaboration.However, the global patent landscape is increasingly complex, with regional differences in examination, cross-border enforcement challenges, and new models like open-source licensing. These demand more sophisticated IP strategies. Key questions now are: How to build a patent system combining international vision with local expertise? How to accelerate innovation through strategic IP management? The answers will determine the biopharmaceutical industry's success in the coming decade. These points are precisely part of the original intent behind hosting this summit and part of the key topics to be discussed with relevant professionals. Join us on Jun 4th-5th! Register now to reserve your place at this exclusive event. Agenda Overview: Day 1 Morning:The integration and challenges of regulatory science and the patent systemü Latest Practices and Future Prospects of Drug Data Protection and Market Exclusivity Systemsü How to Optimize Application Strategies and Quality Management of Biopharmaceutical Patents under the Fast-Track Patent Examination Systemü Patent Challenges in the ADC/Bispecific Antibody 2.0 Eraü A New Balance Under Global Competition and Cooperation: Challenges, Evolution, and Multinational Corporate Strategies of Biopharmaceutical Patent Linkage SystemsDay 1 Afternoon:Maximizing Patent Value and New Commercialization Modelsü Biosimilar Patent Challenge Strategies and Patent Cliff Managementü Patent Due Diligence and Investment Risksü Trade Secrets vs. Patent Trademarks: Biopharmaceutical Innovation Protection Strategies in High-Risk Litigationü Maximizing Innovation Value Using a Composite Intellectual Property Strategy (Patent + Data Protection)ü Intellectual Property Risks and Management in the Context of Supply Chain Restructuring and Digital Therapy ComplianceDay 2 Morning:Global Perspective on Biopharmaceutical R&D and Patent Strategies and Competitionü How to Develop Differentiated Claim Strategies to Cope with Strict Inventiveness/Obviousness Examinations in Various Countriesü Patent Issues and Intellectual Property Risk Prevention in Cross-Border Biopharmaceutical Collaborationü Patent Layout and Cross-Border Expansion Strategies for Pharmaceutical Companiesü Patent Issues in Cross-Border Biopharmaceutical Collaboration and Strategies for Protecting Pharmaceutical Intellectual PropertyDay 2 Afternoon:Opportunities and Legal Challenges of AI in Biotechnology and Pharmaceutical Intellectual Propertyü Patent Challenges and Strategies for AI-Driven Drug Discovery, Gene Editing, and Cell and Gene Therapyü Patent Eligibility and Data Protection in AI-Driven Drug Developmentü Balance and Development of Innovative and Generic Drugs under the Drug Patent Linkage Systemü Deep Integration of AI in Drug Development and Intellectual Property Protection Strategies More details about the topics, please find attached agenda. Partial inviting Companies & Institutions : CNIPAEUIPOWIPOPhIRDAEli Lilly and CompanyNovo NordiskJohnson & JohnsonAbbVieMerck Sharp & DohmeRocheAstraZenecaNovartisPfizerAmgenSanofiGileadSciencesBristol-Myers SquibbVertex PharmaceuticalsRegeneron PharmaceuticalsNovo NordiskChugai PharmaceuticalGSKMerck KGaASun PharmaceuticalCVS HealthDaiichi SankyōLONZATakeda PharmaceuticalHengrui PharmaceuticalsUCBArgenxAlnylam Pharmaceuticals IncCelltrionOtsuka HoldingsGalderma GroupTEVAWuXi AppTecWest PharmaceuticalBeiGeneBiogen IncLabCorpBayerDivis LaboratoriesSandozICONAstellas PharmaModernaBaxterNeurocrine BiosciencesCipla Ltd.,ViatrisHansoh PharmDr. Reddy'sLupin LimitedServierIncyte, CorpGenmabEisaiLuoxin Pharmaceutical GroupCSPC PharmaTide PharmaceuticalBRILLIANT PHARMACEUTICALInnovent BiologicsBio-Thera SolutionsSalubris PharmaceuticalsHaiscom pharmaceuticalEaston BiopharmaceuticalsHua MedicineGenscript CorporationTransThera BiosciencesCHIPSCREEN BIOSCIENCESHumanwell PharmaceuticalFosun Kite BiotechnologyHybio PharmaceuticalAllist PharmaceuticalsXiangxue Life SciencesHumanwell HealthcareXuanZhu PharmaStaidsonShineway PharmaceuticalKanghong PharmaceuticalI-Mab BiopharmaCRDCNew Era PharmaceuticalAscentage PharmaARSUAMOONJiangxi Jemincare GroupYangzijiang PharmaceuticalLintonPharm Co., Ltd.Grand PharmaceuticalQilu PharmaceuticalShanghai PharmaceuticalsKelun PharmaceuticalBuchang PharmaceuticalsLivzon PharmaceuticalSunshineLakeHuahai PharmaceuticalConba Pharmaceutical3SBio Inc.Jiuzhou PharmaceuticalHisun PharmaceuticalSimcere PharmaceuticalBeijing Intellectual Property CourtShanghai Technology ExchangeNhwa Pharmaceutical Tongyuankang PharmaceuticalKangma BiotechnologyRege BiotechZhejiang BaiChengPharmaceuticalTongji UniversityHitGen Inc.Impact TherapeuticsHutchison China MediTechCR Double CraneSinocelltech Gendicine BiopharmaceuticalShenyang Xingqi PharmaceuticalImpact TherapeuticsAsieris PharmaceuticalsMetseraLaNova MedicinesInnolake BiopharmChengdu Guowei BiologicalRibo Life Science Johnson & Johnson MedTechAdlai NortyeKejun PharmaceuticalBeijing Wuhe Boao PharmaceuticalYoujia (Hangzhou) BiotechnologyLyvgen BiopharmaMabwell (Shanghai) BioscienceIASO BioTOT BiopharmSuzhou Gelanke PharmaceuticalBioNTechSanegeneBioMedical Academy of Sciences & ResearchKangbaida (Sichuan) BiologicalShanghai Luoqi BiotechnologyYuekang Kechuang PharmaceuticalSunshineLakeKelun-Bota BiotechChina Biologic ProductsJunhemeng BiotechXiamen Amoytop BiotechYuansong BiotechnologyWuXi BiologicsJ Xinnian PharmaceuticalShanghai Yunsheng Yanxin BiotechSimcere Pharmaceuticalwebsite://en.zvuaz.cn/p/1176775/
引言隨(sui)(sui)著(zhu)(zhu)(zhu)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)產(chan)業(ye)向“新(xin)(xin)(xin)四化(hua)(hua)(hua)”(電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)化(hua)(hua)(hua)、智(zhi)(zhi)(zhi)能(neng)(neng)(neng)(neng)(neng)化(hua)(hua)(hua)、網聯化(hua)(hua)(hua)、共(gong)(gong)享化(hua)(hua)(hua))深度(du)轉(zhuan)型,其(qi)(qi)(qi)(qi)競(jing)爭(zheng)(zheng)核(he)(he)心已(yi)從(cong)(cong)(cong)傳(chuan)(chuan)(chuan)(chuan)(chuan)統(tong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)機(ji)械制造(zao)轉(zhuan)變(bian)為(wei)(wei)(wei)(wei)芯片、軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)、電(dian)(dian)(dian)(dian)(dian)池(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)和(he)(he)(he)(he)(he)智(zhi)(zhi)(zhi)能(neng)(neng)(neng)(neng)(neng)算(suan)法(fa)(fa)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)比(bi)拼。這(zhe)(zhe)使得知(zhi)(zhi)識產(chan)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)(IP)成(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)車(che)(che)(che)(che)(che)(che)企(qi)*關(guan)(guan)鍵的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)資產(chan)和(he)(he)(he)(he)(he)護城河,同時(shi)(shi)(shi)也引發(fa)(fa)(fa)(fa)了(le)全球范圍(wei)內(nei)(nei)日(ri)(ri)(ri)(ri)益(yi)頻繁且復(fu)雜的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)知(zhi)(zhi)識產(chan)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)糾(jiu)紛(fen)(fen)(fen)(fen)。本(ben)案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)集(ji)收錄了(le)2020年(nian)(nian)(nian)(nian)(nian)至(zhi)(zhi)2025年(nian)(nian)(nian)(nian)(nian)間(jian)(jian)具(ju)有代(dai)(dai)(dai)表(biao)性(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)全球汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)IP糾(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)。一(yi)(yi)、 電(dian)(dian)(dian)(dian)(dian)池(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)與(yu)(yu)電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)車(che)(che)(che)(che)(che)(che)核(he)(he)心**糾(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)1:LG化(hua)(hua)(hua)學(xue) vs. SK創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin) (2020-2021年(nian)(nian)(nian)(nian)(nian))時(shi)(shi)(shi)間(jian)(jian): 2020年(nian)(nian)(nian)(nian)(nian)-2021年(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)議(yi)(yi)領(ling)(ling)(ling)域(yu): 電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)池(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(商(shang)(shang)業(ye)秘(mi)密(mi)(mi))案(an)(an)(an)(an)(an)(an)(an)(an)(an)情(qing)摘(zhai)要(yao): 韓國兩(liang)大(da)電(dian)(dian)(dian)(dian)(dian)池(chi)巨頭在(zai)(zai)(zai)(zai)(zai)美國爆發(fa)(fa)(fa)(fa)激烈法(fa)(fa)律戰(zhan)(zhan)(zhan)。LG化(hua)(hua)(hua)學(xue)(現為(wei)(wei)(wei)(wei)LG能(neng)(neng)(neng)(neng)(neng)源(yuan)(yuan)(yuan)(yuan)解(jie)決方(fang)(fang)案(an)(an)(an)(an)(an)(an)(an)(an)(an))指(zhi)控SK創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(SK Innovation)通過雇(gu)傭(yong)其(qi)(qi)(qi)(qi)前(qian)(qian)員工竊(qie)(qie)取了(le)大(da)量(liang)與(yu)(yu)電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)池(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)相關(guan)(guan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)商(shang)(shang)業(ye)秘(mi)密(mi)(mi),包(bao)括關(guan)(guan)于鋰(li)電(dian)(dian)(dian)(dian)(dian)池(chi)隔膜(mo)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)關(guan)(guan)鍵技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)。糾(jiu)紛(fen)(fen)(fen)(fen)結果(guo)(guo): 美國國際貿(mao)易委(wei)員會(ITC)于2021年(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)作(zuo)出(chu)*終(zhong)(zhong)(zhong)裁決,對(dui)(dui)SK創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)發(fa)(fa)(fa)(fa)出(chu)為(wei)(wei)(wei)(wei)期10年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)禁(jin)(jin)止(zhi)令(ling),禁(jin)(jin)止(zhi)其(qi)(qi)(qi)(qi)向美國進口電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)池(chi)、模(mo)塊、電(dian)(dian)(dian)(dian)(dian)池(chi)包(bao)及(ji)相關(guan)(guan)零部件(jian)(jian)。*終(zhong)(zhong)(zhong),在(zai)(zai)(zai)(zai)(zai)拜登政府介(jie)入和(he)(he)(he)(he)(he)雙方(fang)(fang)壓(ya)力(li)下(xia),2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue),雙方(fang)(fang)達(da)成(cheng)(cheng)(cheng)和(he)(he)(he)(he)(he)解(jie)。SK創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)向LG支付(fu)(fu)2萬(wan)(wan)億韓元(約(yue)18億美元)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)賠(pei)(pei)償(chang)(chang)金(jin)(包(bao)括現金(jin)和(he)(he)(he)(he)(he)版稅(shui)),并(bing)撤回(hui)相關(guan)(guan)訴(su)(su)(su)(su)訟(song)(song)(song)。來(lai)源(yuan)(yuan)(yuan)(yuan):United States International Trade Commission. (2021). Certain Lithium Ion Batteries, Battery Cells, Battery Modules, Battery Packs, Components Thereof, and Processes Therefor. Investigation No. 337-TA-1159.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)11日(ri)(ri)(ri)(ri)). LG Energy, SK Innovation reach settlement in battery dispute.案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)2:寧(ning)德(de)時(shi)(shi)(shi)代(dai)(dai)(dai) vs. 中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)航 (2022年(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian))時(shi)(shi)(shi)間(jian)(jian): 2022年(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)議(yi)(yi)領(ling)(ling)(ling)域(yu): 鋰(li)電(dian)(dian)(dian)(dian)(dian)池(chi)結構技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)**(正(zheng)(zheng)極極片、防爆閥(fa)等(deng)(deng))案(an)(an)(an)(an)(an)(an)(an)(an)(an)情(qing)摘(zhai)要(yao): 中(zhong)(zhong)(zhong)(zhong)(zhong)國動(dong)(dong)(dong)(dong)(dong)(dong)(dong)力(li)電(dian)(dian)(dian)(dian)(dian)池(chi)巨頭寧(ning)德(de)時(shi)(shi)(shi)代(dai)(dai)(dai)(CATL)對(dui)(dui)其(qi)(qi)(qi)(qi)競(jing)爭(zheng)(zheng)對(dui)(dui)手中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)航(CALB)發(fa)(fa)(fa)(fa)起(qi)(qi)多項**侵(qin)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)訴(su)(su)(su)(su)訟(song)(song)(song),指(zhi)控其(qi)(qi)(qi)(qi)侵(qin)犯(fan)(fan)了(le)包(bao)括“正(zheng)(zheng)極極片及(ji)電(dian)(dian)(dian)(dian)(dian)池(chi)”、“防爆裝置”在(zai)(zai)(zai)(zai)(zai)內(nei)(nei)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)多項核(he)(he)心**。此案(an)(an)(an)(an)(an)(an)(an)(an)(an)被(bei)(bei)視(shi)為(wei)(wei)(wei)(wei)中(zhong)(zhong)(zhong)(zhong)(zhong)國電(dian)(dian)(dian)(dian)(dian)池(chi)行(xing)(xing)業(ye)史上(shang)*大(da)規模(mo)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)**戰(zhan)(zhan)(zhan)。糾(jiu)紛(fen)(fen)(fen)(fen)結果(guo)(guo): 經(jing)(jing)過多輪庭(ting)審,2023年(nian)(nian)(nian)(nian)(nian),福(fu)建(jian)省(sheng)高級人(ren)民(min)(min)法(fa)(fa)院(yuan)作(zuo)出(chu)終(zhong)(zhong)(zhong)審判(pan)(pan)決,裁定中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)航侵(qin)犯(fan)(fan)寧(ning)德(de)時(shi)(shi)(shi)代(dai)(dai)(dai)兩(liang)項**,需立(li)即停止(zhi)銷(xiao)售侵(qin)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)產(chan)品,并(bing)賠(pei)(pei)償(chang)(chang)寧(ning)德(de)時(shi)(shi)(shi)代(dai)(dai)(dai)總計(ji)(ji)(ji)約(yue)人(ren)民(min)(min)幣(bi)5700萬(wan)(wan)元的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)經(jing)(jing)濟(ji)損失。此外,中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)航還被(bei)(bei)要(yao)求(qiu)支付(fu)(fu)高達(da)數百(bai)萬(wan)(wan)元的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)**許(xu)(xu)可(ke)(ke)費。來(lai)源(yuan)(yuan)(yuan)(yuan):福(fu)建(jian)省(sheng)高級人(ren)民(min)(min)法(fa)(fa)院(yuan) (2023) 閩民(min)(min)終(zhong)(zhong)(zhong)XX號民(min)(min)事(shi)判(pan)(pan)決書(shu)(具(ju)體(ti)案(an)(an)(an)(an)(an)(an)(an)(an)(an)號因(yin)公(gong)(gong)開信(xin)(xin)(xin)息(xi)省(sheng)略)。第一(yi)(yi)財(cai)經(jing)(jing). (2023年(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)21日(ri)(ri)(ri)(ri)). 《寧(ning)德(de)時(shi)(shi)(shi)代(dai)(dai)(dai)與(yu)(yu)中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)航**戰(zhan)(zhan)(zhan)落(luo)幕:中(zhong)(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)航賠(pei)(pei)償(chang)(chang)5700萬(wan)(wan)元》。二、 自(zi)(zi)(zi)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)駕駛(shi)與(yu)(yu)智(zhi)(zhi)(zhi)能(neng)(neng)(neng)(neng)(neng)網聯技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)糾(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)3:Waymo vs. Uber (2020年(nian)(nian)(nian)(nian)(nian)和(he)(he)(he)(he)(he)解(jie)后(hou)延續(xu)(xu)影響(xiang))時(shi)(shi)(shi)間(jian)(jian): 2017年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)(fa)(fa)起(qi)(qi),2020年(nian)(nian)(nian)(nian)(nian)達(da)成(cheng)(cheng)(cheng)和(he)(he)(he)(he)(he)解(jie)但影響(xiang)持續(xu)(xu)。爭(zheng)(zheng)議(yi)(yi)領(ling)(ling)(ling)域(yu): 激光(guang)雷(lei)達(da)(LiDAR)和(he)(he)(he)(he)(he)自(zi)(zi)(zi)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)駕駛(shi)商(shang)(shang)業(ye)秘(mi)密(mi)(mi)案(an)(an)(an)(an)(an)(an)(an)(an)(an)情(qing)摘(zhai)要(yao): 谷(gu)歌旗下(xia)自(zi)(zi)(zi)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)駕駛(shi)公(gong)(gong)司(si)Waymo指(zhi)控其(qi)(qi)(qi)(qi)前(qian)(qian)工程師Anthony Levandowski在(zai)(zai)(zai)(zai)(zai)離(li)職(zhi)前(qian)(qian)下(xia)載了(le)超過1.4萬(wan)(wan)份機(ji)密(mi)(mi)文件(jian)(jian),并(bing)隨(sui)(sui)后(hou)創(chuang)(chuang)(chuang)(chuang)(chuang)辦了(le)自(zi)(zi)(zi)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)駕駛(shi)卡(ka)車(che)(che)(che)(che)(che)(che)公(gong)(gong)司(si)Otto(后(hou)被(bei)(bei)Uber收購(gou)),Uber因(yin)此使用(yong)(yong)了(le)這(zhe)(zhe)些技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)。糾(jiu)紛(fen)(fen)(fen)(fen)結果(guo)(guo): 雙方(fang)(fang)于2018年(nian)(nian)(nian)(nian)(nian)達(da)成(cheng)(cheng)(cheng)和(he)(he)(he)(he)(he)解(jie),但2020年(nian)(nian)(nian)(nian)(nian),該案(an)(an)(an)(an)(an)(an)(an)(an)(an)有了(le)后(hou)續(xu)(xu)進展(zhan)。Anthony Levandowski因(yin)盜(dao)(dao)竊(qie)(qie)商(shang)(shang)業(ye)機(ji)密(mi)(mi)被(bei)(bei)美國法(fa)(fa)院(yuan)判(pan)(pan)處(chu)18個(ge)月(yue)(yue)監(jian)禁(jin)(jin)(后(hou)獲特(te)(te)(te)朗(lang)普特(te)(te)(te)赦)。此案(an)(an)(an)(an)(an)(an)(an)(an)(an)確立(li)了(le)自(zi)(zi)(zi)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)駕駛(shi)領(ling)(ling)(ling)域(yu)商(shang)(shang)業(ye)秘(mi)密(mi)(mi)保(bao)護的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)極端重要(yao)性(xing),為(wei)(wei)(wei)(wei)后(hou)續(xu)(xu)類(lei)似(si)案(an)(an)(an)(an)(an)(an)(an)(an)(an)件(jian)(jian)提(ti)供(gong)(gong)了(le)判(pan)(pan)例(li)(li)。來(lai)源(yuan)(yuan)(yuan)(yuan):United States District Court, Northern District of California. Case No. 3:17-cv-00939-WHA.The New York Times. (2020年(nian)(nian)(nian)(nian)(nian)8月(yue)(yue)5日(ri)(ri)(ri)(ri)). Ex-Google Engineer Avoids Prison After Trump Commutes Sentence.案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)4:特(te)(te)(te)斯拉 vs. 小鵬(peng)(peng)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che) (2019年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)(fa)(fa)起(qi)(qi),2021年(nian)(nian)(nian)(nian)(nian)和(he)(he)(he)(he)(he)解(jie))時(shi)(shi)(shi)間(jian)(jian): 2019年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)(fa)(fa)起(qi)(qi)訴(su)(su)(su)(su)訟(song)(song)(song),2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)達(da)成(cheng)(cheng)(cheng)和(he)(he)(he)(he)(he)解(jie)。爭(zheng)(zheng)議(yi)(yi)領(ling)(ling)(ling)域(yu): 自(zi)(zi)(zi)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)駕駛(shi)源(yuan)(yuan)(yuan)(yuan)代(dai)(dai)(dai)碼(ma)與(yu)(yu)商(shang)(shang)業(ye)秘(mi)密(mi)(mi)案(an)(an)(an)(an)(an)(an)(an)(an)(an)情(qing)摘(zhai)要(yao): 特(te)(te)(te)斯拉起(qi)(qi)訴(su)(su)(su)(su)其(qi)(qi)(qi)(qi)前(qian)(qian)華裔(yi)工程師曹光(guang)植(zhi),指(zhi)控其(qi)(qi)(qi)(qi)在(zai)(zai)(zai)(zai)(zai)入職(zhi)小鵬(peng)(peng)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)前(qian)(qian),將(jiang)(jiang)特(te)(te)(te)斯拉自(zi)(zi)(zi)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)駕駛(shi)系(xi)(xi)統(tong)Autopilot的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)源(yuan)(yuan)(yuan)(yuan)代(dai)(dai)(dai)碼(ma)副本(ben)上(shang)傳(chuan)(chuan)(chuan)(chuan)(chuan)至(zhi)(zhi)其(qi)(qi)(qi)(qi)個(ge)人(ren)iCloud賬戶。小鵬(peng)(peng)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)作(zuo)為(wei)(wei)(wei)(wei)曹光(guang)植(zhi)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)新(xin)(xin)(xin)雇(gu)主(zhu)被(bei)(bei)卷入訴(su)(su)(su)(su)訟(song)(song)(song)。糾(jiu)紛(fen)(fen)(fen)(fen)結果(guo)(guo): 經(jing)(jing)過長達(da)兩(liang)年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)調查和(he)(he)(he)(he)(he)庭(ting)審,雙方(fang)(fang)于2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)達(da)成(cheng)(cheng)(cheng)和(he)(he)(he)(he)(he)解(jie)。特(te)(te)(te)斯拉對(dui)(dui)小鵬(peng)(peng)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)共(gong)(gong)享請求(qiu)表(biao)示(shi)滿意,并(bing)結束了(le)此案(an)(an)(an)(an)(an)(an)(an)(an)(an)。此案(an)(an)(an)(an)(an)(an)(an)(an)(an)凸(tu)顯了(le)中(zhong)(zhong)(zhong)(zhong)(zhong)美科(ke)(ke)技(ji)(ji)(ji)公(gong)(gong)司(si)在(zai)(zai)(zai)(zai)(zai)尖端技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)人(ren)才競(jing)爭(zheng)(zheng)中(zhong)(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)IP沖(chong)突。來(lai)源(yuan)(yuan)(yuan)(yuan):United States District Court, Northern District of California. Case No. 3:19-cv-01463-RS.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)16日(ri)(ri)(ri)(ri)). Tesla settles lawsuit against engineer who moved to Xpeng Motors.(預測(ce)(ce)) 案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)5:某科(ke)(ke)技(ji)(ji)(ji)公(gong)(gong)司(si) vs. 某傳(chuan)(chuan)(chuan)(chuan)(chuan)統(tong)車(che)(che)(che)(che)(che)(che)企(qi) (2025年(nian)(nian)(nian)(nian)(nian)預測(ce)(ce))時(shi)(shi)(shi)間(jian)(jian): 2025年(nian)(nian)(nian)(nian)(nian)(預測(ce)(ce))爭(zheng)(zheng)議(yi)(yi)領(ling)(ling)(ling)域(yu): 大(da)模(mo)型在(zai)(zai)(zai)(zai)(zai)智(zhi)(zhi)(zhi)能(neng)(neng)(neng)(neng)(neng)座艙(cang)中(zhong)(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)應(ying)(ying)用(yong)(yong)**案(an)(an)(an)(an)(an)(an)(an)(an)(an)情(qing)摘(zhai)要(yao): 隨(sui)(sui)著(zhu)(zhu)(zhu)生成(cheng)(cheng)(cheng)式AI大(da)模(mo)型在(zai)(zai)(zai)(zai)(zai)車(che)(che)(che)(che)(che)(che)載語(yu)音助(zhu)手、場(chang)景化(hua)(hua)(hua)服務(wu)中(zhong)(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)深度(du)集(ji)成(cheng)(cheng)(cheng),某家專(zhuan)注于AI技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)科(ke)(ke)技(ji)(ji)(ji)公(gong)(gong)司(si)(如已(yi)布局相關(guan)(guan)**的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)百(bai)度(du)、谷(gu)歌或(huo)(huo)(huo)一(yi)(yi)家初創(chuang)(chuang)(chuang)(chuang)(chuang)公(gong)(gong)司(si))可(ke)(ke)能(neng)(neng)(neng)(neng)(neng)會對(dui)(dui)某家傳(chuan)(chuan)(chuan)(chuan)(chuan)統(tong)車(che)(che)(che)(che)(che)(che)企(qi)巨頭發(fa)(fa)(fa)(fa)起(qi)(qi)**侵(qin)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)訴(su)(su)(su)(su)訟(song)(song)(song),指(zhi)控其(qi)(qi)(qi)(qi)智(zhi)(zhi)(zhi)能(neng)(neng)(neng)(neng)(neng)座艙(cang)系(xi)(xi)統(tong)中(zhong)(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)對(dui)(dui)話式AI、個(ge)性(xing)化(hua)(hua)(hua)推薦(jian)等(deng)(deng)功能(neng)(neng)(neng)(neng)(neng)侵(qin)犯(fan)(fan)了(le)其(qi)(qi)(qi)(qi)自(zi)(zi)(zi)然語(yu)言處(chu)理(NLP)和(he)(he)(he)(he)(he)機(ji)器學(xue)習模(mo)型的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)**權(quan)(quan)(quan)(quan)(quan)(quan)(quan)。潛在(zai)(zai)(zai)(zai)(zai)影響(xiang): 這(zhe)(zhe)類(lei)糾(jiu)紛(fen)(fen)(fen)(fen)將(jiang)(jiang)把汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)IP戰(zhan)(zhan)(zhan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)戰(zhan)(zhan)(zhan)火從(cong)(cong)(cong)硬件(jian)(jian)、傳(chuan)(chuan)(chuan)(chuan)(chuan)統(tong)軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)引向AI算(suan)法(fa)(fa)和(he)(he)(he)(he)(he)數據處(chu)理層面(mian),可(ke)(ke)能(neng)(neng)(neng)(neng)(neng)引發(fa)(fa)(fa)(fa)一(yi)(yi)系(xi)(xi)列(lie)關(guan)(guan)于AI生成(cheng)(cheng)(cheng)內(nei)(nei)容版權(quan)(quan)(quan)(quan)(quan)(quan)(quan)和(he)(he)(he)(he)(he)算(suan)法(fa)(fa)**有效性(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)新(xin)(xin)(xin)法(fa)(fa)律挑戰(zhan)(zhan)(zhan)。三(san)、 軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)與(yu)(yu)用(yong)(yong)戶界(jie)面(mian)(UI)設(she)(she)(she)計(ji)(ji)(ji)糾(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)6:寶馬、奔(ben)馳等(deng)(deng) vs. **主(zhu)張實(shi)體(ti)(PAE) (2020年(nian)(nian)(nian)(nian)(nian)至(zhi)(zhi)今)時(shi)(shi)(shi)間(jian)(jian): 2020年(nian)(nian)(nian)(nian)(nian)持續(xu)(xu)至(zhi)(zhi)今爭(zheng)(zheng)議(yi)(yi)領(ling)(ling)(ling)域(yu): 車(che)(che)(che)(che)(che)(che)載軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)、通信(xin)(xin)(xin)協(xie)議(yi)(yi)等(deng)(deng)基(ji)礎(chu)**案(an)(an)(an)(an)(an)(an)(an)(an)(an)情(qing)摘(zhai)要(yao): 多家汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)制造(zao)商(shang)(shang),包(bao)括寶馬、奔(ben)馳、大(da)眾等(deng)(deng),持續(xu)(xu)成(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)**主(zhu)張實(shi)體(ti)(Patent Assertion Entities,又稱“**流氓”)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)目標。這(zhe)(zhe)些PAE大(da)量(liang)收購(gou)與(yu)(yu)3G/4G通信(xin)(xin)(xin)、導航軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)、車(che)(che)(che)(che)(che)(che)輛遠程信(xin)(xin)(xin)息(xi)處(chu)理等(deng)(deng)相關(guan)(guan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)基(ji)礎(chu)**,然后(hou)向車(che)(che)(che)(che)(che)(che)企(qi)發(fa)(fa)(fa)(fa)起(qi)(qi)大(da)規模(mo)**侵(qin)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)訴(su)(su)(su)(su)訟(song)(song)(song),尋求(qiu)高額許(xu)(xu)可(ke)(ke)費或(huo)(huo)(huo)賠(pei)(pei)償(chang)(chang)。糾(jiu)紛(fen)(fen)(fen)(fen)結果(guo)(guo): 這(zhe)(zhe)是(shi)一(yi)(yi)種持續(xu)(xu)性(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)業(ye)現象(xiang)。車(che)(che)(che)(che)(che)(che)企(qi)通常(chang)選擇(ze)達(da)成(cheng)(cheng)(cheng)許(xu)(xu)可(ke)(ke)協(xie)議(yi)(yi)或(huo)(huo)(huo)進行(xing)(xing)法(fa)(fa)庭(ting)抗辯。例(li)(li)如,2021年(nian)(nian)(nian)(nian)(nian),大(da)陸集(ji)團(Continental)在(zai)(zai)(zai)(zai)(zai)美國*高法(fa)(fa)院(yuan)對(dui)(dui)Avanci等(deng)(deng)**池(chi)發(fa)(fa)(fa)(fa)起(qi)(qi)反壟斷訴(su)(su)(su)(su)訟(song)(song)(song),試圖遏制PAE的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)為(wei)(wei)(wei)(wei),但未能(neng)(neng)(neng)(neng)(neng)成(cheng)(cheng)(cheng)功。這(zhe)(zhe)已(yi)成(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)整個(ge)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)行(xing)(xing)業(ye)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)“隱(yin)形成(cheng)(cheng)(cheng)本(ben)”。來(lai)源(yuan)(yuan)(yuan)(yuan):Juve Patent. (2021年(nian)(nian)(nian)(nian)(nian)多次(ci)報道). Avanci, Nokia lawsuits against Daimler and its suppliers.IAM Media. (2022年(nian)(nian)(nian)(nian)(nian)5月(yue)(yue)10日(ri)(ri)(ri)(ri)). The auto sector’s PAE problem is not going away.四、 設(she)(she)(she)計(ji)(ji)(ji)與(yu)(yu)商(shang)(shang)標糾(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)7:捷(jie)豹路(lu)(lu)(lu)(lu)虎(hu)(hu) vs. 江(jiang)鈴(ling)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che) (2020年(nian)(nian)(nian)(nian)(nian))時(shi)(shi)(shi)間(jian)(jian): 2020年(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)議(yi)(yi)領(ling)(ling)(ling)域(yu): 車(che)(che)(che)(che)(che)(che)型外觀設(she)(she)(she)計(ji)(ji)(ji)案(an)(an)(an)(an)(an)(an)(an)(an)(an)情(qing)摘(zhai)要(yao): 捷(jie)豹路(lu)(lu)(lu)(lu)虎(hu)(hu)(JLR)在(zai)(zai)(zai)(zai)(zai)中(zhong)(zhong)(zhong)(zhong)(zhong)國起(qi)(qi)訴(su)(su)(su)(su)江(jiang)鈴(ling)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che),指(zhi)控其(qi)(qi)(qi)(qi)生產(chan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)陸風X7車(che)(che)(che)(che)(che)(che)型的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)外觀設(she)(she)(she)計(ji)(ji)(ji)抄襲了(le)路(lu)(lu)(lu)(lu)虎(hu)(hu)攬勝極光(guang)(Range Rover Evoque)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)獨特(te)(te)(te)設(she)(she)(she)計(ji)(ji)(ji)。糾(jiu)紛(fen)(fen)(fen)(fen)結果(guo)(guo): 北京市朝陽(yang)(yang)區人(ren)民(min)(min)法(fa)(fa)院(yuan)判(pan)(pan)決捷(jie)豹路(lu)(lu)(lu)(lu)虎(hu)(hu)勝訴(su)(su)(su)(su)。法(fa)(fa)院(yuan)裁定江(jiang)鈴(ling)汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)必須(xu)立(li)即停止(zhi)陸風X7的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)所(suo)有銷(xiao)售、制造(zao)和(he)(he)(he)(he)(he)營銷(xiao)行(xing)(xing)為(wei)(wei)(wei)(wei),并(bing)向捷(jie)豹路(lu)(lu)(lu)(lu)虎(hu)(hu)支付(fu)(fu)賠(pei)(pei)償(chang)(chang)金(jin)。此案(an)(an)(an)(an)(an)(an)(an)(an)(an)是(shi)中(zhong)(zhong)(zhong)(zhong)(zhong)國法(fa)(fa)院(yuan)保(bao)護外資企(qi)業(ye)外觀設(she)(she)(she)計(ji)(ji)(ji)產(chan)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)標志(zhi)性(xing)案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)。來(lai)源(yuan)(yuan)(yuan)(yuan):北京市朝陽(yang)(yang)區人(ren)民(min)(min)法(fa)(fa)院(yuan) (2019) 京0105民(min)(min)初XX號民(min)(min)事(shi)判(pan)(pan)決書(shu)。BBC News. (2020年(nian)(nian)(nian)(nian)(nian)3月(yue)(yue)26日(ri)(ri)(ri)(ri)). Jaguar Land Rover wins Chinese copycat case.(預測(ce)(ce)) 案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)8:Cybertruck設(she)(she)(she)計(ji)(ji)(ji)元素爭(zheng)(zheng)議(yi)(yi) (2024-2025年(nian)(nian)(nian)(nian)(nian)預測(ce)(ce))時(shi)(shi)(shi)間(jian)(jian): 2024年(nian)(nian)(nian)(nian)(nian)末-2025年(nian)(nian)(nian)(nian)(nian)(預測(ce)(ce))爭(zheng)(zheng)議(yi)(yi)領(ling)(ling)(ling)域(yu): 標志(zhi)性(xing)外觀設(she)(she)(she)計(ji)(ji)(ji)案(an)(an)(an)(an)(an)(an)(an)(an)(an)情(qing)摘(zhai)要(yao): 隨(sui)(sui)著(zhu)(zhu)(zhu)特(te)(te)(te)斯拉Cybertruck的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)正(zheng)(zheng)式交(jiao)付(fu)(fu)和(he)(he)(he)(he)(he)其(qi)(qi)(qi)(qi)**未來(lai)感的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)棱(leng)(leng)角(jiao)設(she)(she)(she)計(ji)(ji)(ji)成(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)標志(zhi),其(qi)(qi)(qi)(qi)他車(che)(che)(che)(che)(che)(che)企(qi)(尤其(qi)(qi)(qi)(qi)是(shi)新(xin)(xin)(xin)興電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)車(che)(che)(che)(che)(che)(che)品牌或(huo)(huo)(huo)小眾制造(zao)商(shang)(shang))若推出(chu)類(lei)似(si)棱(leng)(leng)角(jiao)分明的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)皮卡(ka)或(huo)(huo)(huo)SUV車(che)(che)(che)(che)(che)(che)型,特(te)(te)(te)斯拉可(ke)(ke)能(neng)(neng)(neng)(neng)(neng)會采取強硬的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)法(fa)(fa)律行(xing)(xing)動(dong)(dong)(dong)(dong)(dong)(dong)(dong),主(zhu)張其(qi)(qi)(qi)(qi)獨特(te)(te)(te)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)設(she)(she)(she)計(ji)(ji)(ji)語(yu)言受保(bao)護,從(cong)(cong)(cong)而引發(fa)(fa)(fa)(fa)新(xin)(xin)(xin)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)設(she)(she)(she)計(ji)(ji)(ji)**糾(jiu)紛(fen)(fen)(fen)(fen)。潛在(zai)(zai)(zai)(zai)(zai)影響(xiang): 這(zhe)(zhe)將(jiang)(jiang)測(ce)(ce)試汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)設(she)(she)(she)計(ji)(ji)(ji)**在(zai)(zai)(zai)(zai)(zai)“非傳(chuan)(chuan)(chuan)(chuan)(chuan)統(tong)”造(zao)型上(shang)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)保(bao)護范圍(wei)。總結與(yu)(yu)趨(qu)勢(shi)分析主(zhu)戰(zhan)(zhan)(zhan)場(chang)轉(zhuan)移(yi): 從(cong)(cong)(cong)傳(chuan)(chuan)(chuan)(chuan)(chuan)統(tong)內(nei)(nei)燃(ran)機(ji)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)全面(mian)轉(zhuan)向電(dian)(dian)(dian)(dian)(dian)池(chi)、電(dian)(dian)(dian)(dian)(dian)驅、電(dian)(dian)(dian)(dian)(dian)控、智(zhi)(zhi)(zhi)能(neng)(neng)(neng)(neng)(neng)座艙(cang)和(he)(he)(he)(he)(he)自(zi)(zi)(zi)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)駕駛(shi)軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)算(suan)法(fa)(fa)。爭(zheng)(zheng)議(yi)(yi)類(lei)型多樣化(hua)(hua)(hua): 從(cong)(cong)(cong)**侵(qin)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)擴展(zhan)到商(shang)(shang)業(ye)秘(mi)密(mi)(mi)盜(dao)(dao)竊(qie)(qie)、軟(ruan)(ruan)(ruan)(ruan)件(jian)(jian)著(zhu)(zhu)(zhu)作(zuo)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)、UI/UX設(she)(she)(she)計(ji)(ji)(ji)**以(yi)及(ji)標準必要(yao)**(SEP)許(xu)(xu)可(ke)(ke)費糾(jiu)紛(fen)(fen)(fen)(fen)。主(zhu)體(ti)多元化(hua)(hua)(hua): 參與(yu)(yu)方(fang)(fang)不再僅是(shi)車(che)(che)(che)(che)(che)(che)企(qi),科(ke)(ke)技(ji)(ji)(ji)公(gong)(gong)司(si)、零部件(jian)(jian)供(gong)(gong)應(ying)(ying)商(shang)(shang)、電(dian)(dian)(dian)(dian)(dian)池(chi)制造(zao)商(shang)(shang)、**運營實(shi)體(ti)(NPEs/PAEs) 都深度(du)參與(yu)(yu)其(qi)(qi)(qi)(qi)中(zhong)(zhong)(zhong)(zhong)(zhong)。地域(yu)全球化(hua)(hua)(hua): 中(zhong)(zhong)(zhong)(zhong)(zhong)美歐成(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)*主(zhu)要(yao)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)IP糾(jiu)紛(fen)(fen)(fen)(fen)戰(zhan)(zhan)(zhan)場(chang),尤其(qi)(qi)(qi)(qi)是(shi)中(zhong)(zhong)(zhong)(zhong)(zhong)國,隨(sui)(sui)著(zhu)(zhu)(zhu)本(ben)土車(che)(che)(che)(che)(che)(che)企(qi)和(he)(he)(he)(he)(he)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)公(gong)(gong)司(si)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)崛起(qi)(qi),其(qi)(qi)(qi)(qi)國內(nei)(nei)和(he)(he)(he)(he)(he)國際IP訴(su)(su)(su)(su)訟(song)(song)(song)活動(dong)(dong)(dong)(dong)(dong)(dong)(dong)顯著(zhu)(zhu)(zhu)增加。和(he)(he)(he)(he)(he)解(jie)成(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)常(chang)態: 鑒于訴(su)(su)(su)(su)訟(song)(song)(song)成(cheng)(cheng)(cheng)本(ben)高昂、技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)復(fu)雜性(xing)高且可(ke)(ke)能(neng)(neng)(neng)(neng)(neng)影響(xiang)供(gong)(gong)應(ying)(ying)鏈,許(xu)(xu)多案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)*終(zhong)(zhong)(zhong)以(yi)和(he)(he)(he)(he)(he)解(jie)和(he)(he)(he)(he)(he)交(jiao)叉許(xu)(xu)可(ke)(ke)告終(zhong)(zhong)(zhong),但前(qian)(qian)提(ti)是(shi)雙方(fang)(fang)實(shi)力(li)對(dui)(dui)等(deng)(deng)。說明: 2025年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)案(an)(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)基(ji)于當前(qian)(qian)行(xing)(xing)業(ye)動(dong)(dong)(dong)(dong)(dong)(dong)(dong)態和(he)(he)(he)(he)(he)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)發(fa)(fa)(fa)(fa)展(zhan)趨(qu)勢(shi)進行(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)合(he)理預測(ce)(ce),旨在(zai)(zai)(zai)(zai)(zai)提(ti)供(gong)(gong)前(qian)(qian)瞻性(xing)視(shi)角(jiao)。實(shi)際發(fa)(fa)(fa)(fa)生的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)事(shi)件(jian)(jian)請以(yi)未來(lai)官(guan)方(fang)(fang)發(fa)(fa)(fa)(fa)布的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)信(xin)(xin)(xin)息(xi)為(wei)(wei)(wei)(wei)準。Ann Tel: +86 021-60778889- 808新(xin)(xin)(xin)能(neng)(neng)(neng)(neng)(neng)源(yuan)(yuan)(yuan)(yuan)與(yu)(yu)智(zhi)(zhi)(zhi)能(neng)(neng)(neng)(neng)(neng)網聯汽(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)知(zhi)(zhi)識產(chan)權(quan)(quan)(quan)(quan)(quan)(quan)(quan)創(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)峰會2025組委(wei)會2025 NEV & ICV IP Innovation Summit//zvuaz.cn/p/554988